PEBP4 and breast carcinoma: Overexpressing in a wide range of solid tumors including breast cancer, ovarian cancer and prostate cancer, hPEBP4 has been demonstrated to inhibit apoptosis of cancer cells by regulating the degradation of apoptotic molecules, such as Bcl-2/Bcl-X and Caspase-3 [5]–[8].